These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17975491

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
    Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF, Lafitte JJ, Sculier JP, European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
    J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer.
    Tomita M, Shimizu T, Ayabe T, Onitsuka T.
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):244-7. PubMed ID: 22897792
    [Abstract] [Full Text] [Related]

  • 26. Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
    Yamamoto T, Kadoya N, Shirata Y, Kaneta T, Koto M, Umezawa R, Ishikawa Y, Kubozono M, Sugawara T, Matsushita H, Abe K, Takeda K, Jingu K.
    Ann Nucl Med; 2015 Oct; 29(8):666-73. PubMed ID: 26040413
    [Abstract] [Full Text] [Related]

  • 27. Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation.
    Huang TW, Hsieh CM, Chang H, Cheng YL, Tzao C, Huang WS, Lee SC.
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):869-73. PubMed ID: 22219418
    [Abstract] [Full Text] [Related]

  • 28. Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
    Lee HY, Lee KS, Park J, Han J, Kim BT, Kwon OJ, Ahn YC, Ahn MJ, Park K, Kim J, Shim YM.
    Acad Radiol; 2012 Apr; 19(4):440-5. PubMed ID: 22265854
    [Abstract] [Full Text] [Related]

  • 29. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    Hyun SH, Lee KH, Choi JY, Kim BT, Kim J, Zo JI, Kim H, Kwon OJ, Ahn HK.
    PLoS One; 2015 Apr; 10(12):e0145020. PubMed ID: 26684001
    [Abstract] [Full Text] [Related]

  • 30. Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment: Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung Cancer.
    Pöttgen C, Gauler T, Bellendorf A, Guberina M, Bockisch A, Schwenzer N, Heinzelmann F, Cordes S, Schuler MH, Welter S, Stamatis G, Friedel G, Darwiche K, Jöckel KH, Eberhardt W, Stuschke M.
    J Clin Oncol; 2016 Jul 20; 34(21):2526-33. PubMed ID: 27247220
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-up.
    Konings R, van Gool MH, Bard MP, Zwijnenburg A, Titulaer BM, Aukema TS, Valdés Olmos RA, Sikorska K, Klomp HM, Rijna H.
    Ann Nucl Med; 2016 Jun 20; 30(5):362-8. PubMed ID: 26961089
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K, Maeda A, Yukawa T, Nojima Y, Saisho S, Okita R, Nakata M.
    World J Surg Oncol; 2014 Nov 13; 12():343. PubMed ID: 25392182
    [Abstract] [Full Text] [Related]

  • 37. Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction.
    Ohtaka K, Hida Y, Kaga K, Okamoto S, Shiga T, Tamaki N, Muto J, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2013 Nov 13; 33(11):5193-8. PubMed ID: 24222169
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.